Transcriptional activities of cholecystokinin promoter haplotypes and their relevance to panic disorder susceptibility
- 26 November 2002
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 118B (1), 32-35
- https://doi.org/10.1002/ajmg.b.10058
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Identification of a compound short tandem repeat stretch in the 5′-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophreniaMolecular Psychiatry, 2001
- Genomewide survey of panic disorderAmerican Journal of Medical Genetics, 2001
- Function of the C−36 to T polymorphism in the human cholecystokinin gene promoterMolecular Psychiatry, 2000
- Involvement of Sp1 and Microsatellite Repressor Sequences in the Transcriptional Control of the Human CD30 GeneThe American Journal of Pathology, 2000
- Association between polymorphism of the cholecystokinin gene and idiopathic Parkinson's diseaseClinical Genetics, 1999
- Linked polymorphisms upstream of exons 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorderMolecular Psychiatry, 1998
- Sequence-specific and length-dependent interaction of C 2 H 2 zinc fingers and (TA) n microsatellitesHuman Genetics, 1996
- Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic DisorderArchives of General Psychiatry, 1991
- Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic DisorderThe Canadian Journal of Psychiatry, 1990
- Cholecystokinin Tetrapeptide Induces Panic-like Attacks in Healthy VolunteersArchives of General Psychiatry, 1989